Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Patterns of surveillance for late effects of BCR-ABL tyrosine kinase inhibitors in survivors of pediatric Philadelphia chromosome positive leukemias

Fig. 1

Cardiac and endocrine surveillance independent of clinical trial requirements in patients with CML. a Echocardiogram (ECHO) – each circle is an ECHO. b Electrocardiogram (EKG) – each square is an EKG. c Thyroid stimulating hormone (TSH) – each diamond is a TSH. Each line represents a patient. Lines begin at diagnosis (time 0) and continue until censoring (black X). Solid-filled shapes identify surveillance done outside of clinical trial requirements. Patients with clinical trial requirements for surveillance (N = 2 ECHO, N = 3 EKG, TSH) are not included in the charts. DXA is not shown because only one patient had a DXA outside of clinical trial requirements

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us